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ABSTRACT
Background: Inorganic nitrate, abundant in leafy green vegetables
and beetroot, is thought to have protective health benefits. Adherence
to a Mediterranean diet reduces the incidence and severity of
coronary artery disease, whereas supplementation with nitrate can
improve submaximal exercise performance. Once ingested, oral
commensal bacteria may reduce nitrate to nitrite, which may
subsequently be reduced to nitric oxide during conditions of hypoxia
and in the presence of “nitrite reductases” such as heme- and
molybdenum-containing enzymes.
Objective: We aimed to explore the putative effects of inorganic
nitrate and nitrite on mitochondrial function in skeletal muscle.
Methods: Mice were subjected to a nitrate/nitrite-depleted diet for
2 wk, then supplemented with sodium nitrate, sodium nitrite, or
sodium chloride (1 g/L) in drinking water ad libitum for 7 d before
killing. Skeletal muscle mitochondrial function and expression of
uncoupling protein (UCP) 3, ADP/ATP carrier protein (AAC) 1
and AAC2, and pyruvate dehydrogenase (PDH) were assessed by
respirometry and Western blotting. Studies were also undertaken in
human skeletal muscle biopsies from a cohort of coronary artery
bypass graft patients treated with either sodium nitrite (30-min
infusion of 10 μmol/min) or vehicle [0.9% (wt:vol) saline] 24 h
before surgery.
Results: Neither sodium nitrate nor sodium nitrite supplementation
altered mitochondrial coupling efficiency in murine skeletal muscle,
and expression ofUCP3,AAC1, or AAC2, and PDHphosphorylation
status did not differ between the nitrite and saline groups. Similar
results were observed in human samples.
Conclusions: Sodium nitrite failed to improve mitochondrial
metabolic efficiency, rendering this mechanism implausible for the
purported exercise benefits of dietary nitrate supplementation. This
trial was registered at clinicaltrials.gov as NCT04001283. Am J
Clin Nutr 2019;00:1–11.
Keywords: nitrate, nitrite, mitochondria, uncoupling proteins,
pyruvate dehydrogenase
Introduction
Recent data suggest that there are considerable health benefits
(particularly cardiovascular) from diets high in inorganic nitrate
(NO−3 ). The nitrate (NO
−
3 )–nitrite (NO
−
2 )–nitric oxide (NO)
pathway, whereby dietary inorganic nitrate is processed via the
entero-salivary circuit to release NO−2 and NO (1), is attracting
considerable interest. Adherence to a Mediterranean-style diet
(typically rich in dietary nitrates) is associated with a lower risk
of developing coronary artery disease or heart failure (2, 3).
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In healthy individuals, increased dietary nitrate consumption
has been shown to reduce the oxygen cost of skeletal muscle
work during submaximal exercise, implying increased metabolic
efficiency (4–8); in clinical settings, a regime of dietary nitrate
supplementation improved exercise performance in heart failure
with preserved ejection fraction (HFpEF) and muscle contractile
function in heart failure with reduced ejection fraction (HFrEF)
(9, 10). However, each of these studies was limited by their small
sample size. The recent, comparatively large, INDIE (Inorganic
Nitrite Delivery to Improve Exercise Capacity) trial (utilizing
inhaled nitrite) showed no benefit on exercise capacity in HFpEF
(11). It is unclear whether the smaller studies were false positives,
or whether the shorter plasma half-life of the inhaled nitrite
approach failed to work because of the pulsatile rather than
sustained nature of elevation of nitrite.
Oral inorganic nitrate ingestion has also been documented to
lower blood pressure (5, 12–14), and nitrite has been shown
to inhibit platelet aggregation (15, 16), promote vasodilation
(17), ameliorate pulmonary hypertension (18–20), and attenuate
cardiac ischemia-reperfusion injury in experimental models
(21, 22).
The physiological mechanisms underlying these apparent
improvements in metabolic efficiency are not well understood. It
has been proposed that ingestion of inorganic nitrate can improve
mitochondrial coupling efficiency (i.e., the relationship between
mitochondrial respiration and ATP generation) via reduced
expression of proteins believed to facilitate mitochondrial proton
leak [e.g., the ADP/ATP carrier proteins (AACs) and uncoupling
proteins (UCPs)] (6). However, recent work has cast doubt on
these findings. Whitfield et al. (23) observed a reduction in whole
body oxygen consumption in response to beetroot juice with no
alteration in mitochondrial coupling efficiency (23). Similarly,
Monaco et al. (24) demonstrated improved hemodynamics with
no change in cardiac mitochondrial coupling efficiency in
response to oral sodium nitrate (24). An alternative mechanism
would entail a shift in the Randle cycle [see Hue and Taegtmeyer
(25) for a review] away from fatty acids toward glucose utilization
with increased coupling of glycolysis to carbohydrate oxidation,
which would be accompanied by increased efficiency with
respect to oxygen consumption. Previous work has reported that
inorganic nitrate is capable of increasing skeletal muscle glucose
utilization in the context of type 2 diabetes (26, 27).
The aforementioned studies have largely focused on inves-
tigating sodium nitrate supplementation, as opposed to sodium
nitrite, the putative “active principle” of inorganic nitrate. Given
the limitations of entero-salivary conversion of sodium nitrate
to sodium nitrite, the following investigation sought to elucidate
the molecular mechanisms whereby sodium nitrite may improve
metabolic efficiency in skeletal muscle.
Methods
Treatment conditions
Male C57/bl6 mice, 3–5 mo old, were obtained from Harlan
Laboratory UK Ltd and the University of East Anglia Disease
Modelling Unit. After a 2-wk acclimatization period to local
vivarium conditions, mice were subjected to a nitrate/nitrite-
depleted diet for 2 wk. Mice were then administered either
sodium chloride, sodium nitrate, or sodium nitrite at a concentra-
tion of 1 g/L in drinking water ad libitum for 7 d. All experimental
procedures and protocols used in this study were reviewed and
approved by the Animal Welfare and Ethical Review Body and
were conducted according to the specifications of the United
Kingdom Animals (Scientific Procedures) Act, 1986.
Determination of plasma nitrate/nitrite concentrations
Mice were anaesthetized using 5% isoflurane and 4 L/min
oxygen, and blood was collected via intracardiac puncture into
EDTA-containing anticoagulant tubes containing 100 μL 10 mM
N-ethylmaleimide. Plasma was generated by centrifugation at
2000 × g for 10 min at room temperature, then snap-frozen
using liquid nitrogen and stored at −80◦C until analysis.
Plasma concentrations of nitrate and nitrite were determined
by a dedicated HPLC system (ENO-20; Eicom), as previously
reported (28).
Mitochondrial isolation
A subsequent cohort of mice (C57/bl6 mice, 3–5 mo old)
were killed by cervical dislocation and gastrocnemius muscle
samples harvested from both hind limbs were finely dissected
in 1 mL cold isolation buffer (100 mM sucrose, 100 mM
KCl, 50 mM Tris-HCL, 1 mM KH2PO4, 0.1 mM EDTA, and
0.2% BSA; pH 7.2) and washed, before incubating with 12
U/g protease (Sigma-Aldrich) in 5 mL isolation buffer for 2
min on ice. The tissue was removed from the protease by brief
centrifugation (200 × g for 5 min at 4◦C) and resuspended
in 20 mL fresh isolation buffer. The suspension was then
transferred into a Dounce homogenizer and homogenized using
10 up-and-down strokes on ice, before centrifugation at 700
× g for 10 min at 4◦C. The supernatants were filtered (70
μm cell strainer) and centrifuged at 8000 × g for 10 min at
4◦C. The pellets were resuspended in cold isolation buffer and
centrifuged at 7000 × g for 10 min at 4◦C. Isolated mitochondria
were resuspended in 150 μL suspension buffer (225 mM
mannitol, 75 mM sucrose, 10 mM Tris, and 0.1 mM EDTA; pH
7.2), assayed for protein content (Pierce BCA Protein Assay Kit;
ThermoFisher Scientific), and kept on ice until further use.
Mitochondrial respiration
Seahorse XF24 analyzer.
The oxygen consumption rate (OCR) of mitochondria isolated
from murine skeletal muscle was initially measured using
an XF24 analyzer (Seahorse Bioscience). The mitochondrial
suspension was deposited onto XF24 cell culture microplates
(Seahorse Bioscience) at a concentration of 2.5 μg/50 μL inmito-
chondrial assay solution (MAS) buffer [70 mM sucrose, 220 mM
mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES,
1.0 mM EGTA, and 0.2% (wt:vol) fatty acid–free BSA; pH
7.2] containing 10 mM pyruvate/5 mM malate (mitochondrial
complex I substrate). The plates were centrifuged at 2000 × g
for 20 min at 4◦C. Prewarmed (37◦C) MAS buffer containing
complex I substrate was added to the equivalent wells to a
final volume of 495 μL. The plate was equilibrated in a carbon
dioxide–free incubator for 8 min at 37◦C, then placed in the
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FIGURE 1 A schematic of the trial design (acute phase) for the “Effect of Nitrite on Cardiac Muscle and Blood Vessels in Patients Undergoing Coronary
Artery Bypass Grafting Surgery” study.
analyzer. OCR was measured in triplicate at baseline, and after
sequential addition of 4 mM ADP, 2.5 μg/μL oligomycin, 4 μM
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP),
and 4 μM antimycin A (mitochondrial “stress test”) according
to the manufacturer’s instructions. The OCRs were used to
determine maximal mitochondrial respiration (FCCP-induced
OCR minus antimycin A OCR), leak (oligomycin-induced OCR
minus antimycin A OCR), and the respiratory control ratios
(ADP-induced OCR:oligomycin-induced OCR), accordingly.
Oxygen electrode.
For a more detailed analysis of respiratory function, mitochon-
drial oxygen uptake activity was measured using a Clark-type
oxygen electrode (Oxytherm; Hansatech), calibrated following
the manufacturer’s instructions. Aliquots (0.75 mg) of isolated
muscle mitochondria were suspended in 1.5 mL air-saturated
MAS buffer at 37◦C with the addition of 10 mM pyruvate/5 mM
malate to initiate mitochondrial oxygen uptake activity (at an
acquisition rate of 5 Hz, stirring at 27 rpm). For the assessment
of key respiratory parameters, OCRs were measured after the
sequential addition of 4 mM ADP (to initiate maximal “state 3”
respiration), 5 μM oligomycin (to measure the rate associated
with proton leak), 7 μM carboxyatractyloside (to determine the
contribution of AAC to the proton leak rate), 2 μM FCCP (to
give the maximal uncoupled activity), and 2 μg/mL antimycin
A (to fully inhibit mitochondrial respiration). Alternatively, 2
sequential additions of 400 nmol ADP (ε259 = 15,400 M−1/cm)
were used to induce transient state 3 rates for phosphate:oxygen
(P:O) ratio determination. The corresponding amount of oxygen
consumed during each state 3 burst was estimated as described
in Brown and Cooper (29). Importantly, the order in which
“treated” and “control” samples were measured in the electrode
was alternated each day to avoid any time-dependent effects (e.g.,
uncoupling) inadvertently being ascribed to one mitochondrial
sample type over the other.
Immunoblotting
Mouse tissue.
Mice were killed by cervical dislocation. Gastrocnemius
muscle was harvested, snap-frozen in liquid nitrogen, then stored
at −80◦C. Tissue samples were homogenized in lysis buffer (100
mM Tris-HCl, 2 mM Na3VO4, and 5 mM NaF; pH 7.4) using
a mortar and pestle. Homogenate was subject to 3 freeze–thaw
cycles using liquid nitrogen, then centrifuged at 14,000 × g for
15 min at 4◦C. Supernatants were retained and stored at −20◦C.
Total extracted protein was determined by Bradford assay.
SDS-PAGE was conducted under reducing conditions.
Samples were loaded in Laemmli buffer containing β-
mercaptoethanol, at 20 μg total protein per lane in 10%
acrylamide gels. Electrophoresis was conducted at 60 V for
20 min, then 120 V for 80 min. Separated proteins were
transferred onto 0.2 μm polyvinylidene difluoride (PVDF)
membrane (Bio-Rad) at 100 V for 75 min. Membranes were
blocked in 5% (wt:vol) commercially available fat-free milk
in 0.1% (vol:vol) Tris-buffered saline (TBS)-Tween for 1 h
at room temperature. All antibodies were diluted using
5% (wt:vol) fat-free milk in 0.1% (vol:vol) TBS-Tween.
Primary antibodies (Uncoupling Protein 3, 1:500 dilution,
Abcam; Pan-Adenine Nucleotide Translocase, 1:500 dilution,
Santa-Cruz) were incubated overnight at 4◦C, followed by
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FIGURE 2 Plasma NO−3 and NO
−
2 concentrations in mice after
supplementation with sodium nitrate (n = 10–13 per group) or sodium
nitrite (n = 6 per group) for 7 d. (A) Plasma NO−3 concentrations in
mice supplemented with sodium nitrate or sodium nitrite. (B) Plasma NO−2
concentrations in mice supplemented with sodium nitrate or sodium nitrite.
incubation with anti-rabbit or anti-goat horseradish peroxidase–
conjugated secondary antibodies at 1:5000 dilution (Cell
Signaling Technology) for 1 h at room temperature. Proteins
were visualized using chemiluminescent substrate (ECL:
2.5 mM luminol, 0.4 mM coumaric acid, hydrogen peroxide)
and imaged in a Fusion SL imager (Peqlab). After visualization,
membranes were stained with 0.2% (wt:vol) Coomassie blue for
normalization to the amount of protein per lane (30). Images
were analyzed using ImageJ (NIH).
Human tissue.
Participants were recruited into the “Effect of Nitrite on
Cardiac Muscle and Blood Vessels in Patients Undergoing Coro-
nary Artery Bypass Grafting Surgery” study (NCT04001283),
a randomized, placebo-controlled, double-blind clinical study
investigating the potential mechanisms underlying sodium nitrite
as a medical therapy (Figure 1). Eligible participants were
patients undergoing coronary artery bypass graft (CABG)
surgery, with reasons for exclusion being inability to provide
informed consent, pregnancy or of child-bearing potential, type
1 diabetes mellitus, New York Heart Association class III–IV
heart failure with left ventricular ejection fraction <40%, renal
impairment requiring dialysis, and unstable coronary syndrome
(occurring within the preceding 2 wk). Study participants were
randomly assigned into either the treatment (sodium nitrite
10 μmol/min infused over a period of 30 min) or control [0.9%
(wt:vol) saline–infused equivolume over a period of 30 min]
FIGURE 3 Expression of UCP3 and AAC proteins in mouse skeletal
muscle after 7 d dietary supplementation with sodium nitrate (n = 12
per group) or sodium nitrite (n = 7–8 per group). (A) UCP3 and (B)
AAC expression were unchanged by sodium nitrate or sodium nitrite
supplementation. AAC, ADP/ATP carrier protein; AU, arbitrary units; C,
control; N, nitrate/nitrite; UCP, uncoupling protein.
arms, with blood samples collected immediately before and
after infusion, then 6 h and 24 h postinfusion, and at time
of biopsy. Infusion occurred 24 h before scheduled surgery.
Skeletal muscle (pectoral muscle), right atrial appendage, and
left ventricular biopsies were collected immediately before aortic
cross-clamping, snap-frozen using liquid nitrogen, and stored at
−80◦C until analysis. The studywas approved by the institutional
Ethics of Human Research Committee and complied with the
Declaration of Helsinki. Written informed consent was obtained
in all cases.
Samples were snap-frozen in liquid nitrogen, after which
100–150 μL NP40 cell lysis buffer (ThermoFisher Scientific)
containing a Halt protease and phosphatase inhibitor cocktail
(ThermoFisher Scientific) was added. Samples were manually
crushed, then homogenized on ice using a Pellet Pestle (Sigma-
Aldrich). Samples were then snap-frozen using liquid nitrogen
and allowed to thaw on ice, after which they were homogenized
for a second time. Samples then underwent a further 2 freeze–
thaw cycles using liquid nitrogen, mixing on a vortex after
thawing each time. Samples then underwent centrifugation
at 16,700 × g for 10 min at 4◦C; the supernatants were
collected and stored at −80◦C. Protein determination was
performed using the Bio-Rad DC Assay (Bio-Rad). Sam-
ples were loaded into Laemmli buffer at a concentration of
1.5 mg/mL and underwent SDS-PAGE using 10% acrylamide
gels under reducing conditions for ∼1 h at 0.08 A, after which
they were transferred onto PVDF membrane (GE Healthcare)
for ∼1.5 h at 0.38 A. Membranes were subsequently blocked
for a minimum of 2 h in either 5% (wt:vol) BSA or skim milk
in TBS-Tween, as appropriate. Primary antibody targets were
Uncoupling Protein-3 (1:1000, Abcam), Adenine Nucleotide
Translocase 1 (1:1000, Abcam), Adenine Nucleotide Translocase
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FIGURE 4 Protein expression and phosphorylation status of PDH in mouse skeletal muscle in response to dietary sodium nitrate (n = 12 per group) or
sodium nitrite (n = 8 per group) supplementation. Sodium nitrate, but not sodium nitrite, supplementation resulted in dephosphorylation of serines 293 and
300 of the PDH complex in mouse skeletal muscle. ∗,∗∗Significant differences: ∗P < 0.01, ∗∗P < 0.001, compared with control. White bars, NaCl; black bars,
NaNO3; gray bars, NaNO2. AU, arbitrary units; C, control; N, nitrate/nitrite; PDH, pyruvate dehydrogenase.
2 (1:1000, Cell Signaling Technology), Phospho(serine 232)-
PDH (1:2000, Calbiochem), Phospho(serine 293)-PDH (1:1000,
Abcam), Phospho(serine 300)-PDH (1:1000, Calbiochem), PDH
(1:1000, Cell Signaling Technology), and Vinculin (1:1000,
Abcam). Secondary detection was done using horseradish
peroxidase–conjugated goat anti-rabbit (1:1000, Cell Signaling
Technology) or goat anti-mouse (1:1500, Dako) antibodies.
Membranes were developed using Pierce ECL western blot-
ting substrate (ThermoFisher Scientific) and images captured
using a ChemiDoc-It2 imager (Ultra-Violet Products Ltd) with
VisionWorksLS 8.1.2 software (Ultra-Violet Products Ltd).
Images were analyzed using ImageJ and normalized to Vinculin
expression.
Pyruvate dehydrogenase activity
The activity of the active form (i.e., dephosphorylated)
of pyruvate dehydrogenase (PDH) was determined through
acetyl-CoA formation, measured after condensation with ra-
dioactive oxaloacetate to form citrate, as previously reported
(31, 32).
Statistics
All data are expressed as mean ± SD unless stated otherwise.
Differences between groups were analyzed by independent t
test or ANOVA (as appropriate) for parametric data or Mann–
Whitney U test for nonparametric data. Frequency distributions
across treatment groups were assessed by χ2 test. The human
studies were powered in order to detect a treatment difference
of 20% in expression and phosphorylation status of metabolic
proteins (i.e., PDH, UCP3, AAC1, and AAC2), as determined
by immunoblotting. Based on an assumed CV of 20%, n = 14
patients per group would be required for 80% confidence at a
2-sided α of 0.05. Similarly, in murine experiments a treatment
difference of 15% in leak respiration (oligomycin respiration
minus antimycin A respiration) would require n= 8 per group for
80% confidence at a 2-sided α of 0.05. Analyses were performed
using GraphPad Prism version 7.01 or IBM SPSS Statistics
version 25.0.0.1.
Results
Murine uptake of supplemented sodium nitrate or nitrite
Plasma concentrations of NO−3 and NO
−
2 after 7 d supple-
mentation of mice with sodium nitrate or sodium nitrite are
depicted in Figure 2. Supplementation with sodium nitrate
resulted in an ∼7-fold increase in plasma NO−3 concentrations
(227 ± 103 μM compared with 33 ± 10 μM, P < 0.0001),
with a nonsignificant trend toward increased plasma NO−2
concentrations (4 ± 3 μM compared with 2 ± 1 μM, P = 0.09).
This result may be indicative of a limited entero-salivary circuit
for reduction of NO−3 to NO
−
2 (33), because supplementation with
sodium nitrite achieved robust increases in both plasma NO−3
(117 ± 62 μM compared with 41 ± 15 μM, P < 0.05) and
plasma NO−2 (10.7 ± 10.5 μM compared with 1.7 ± 0.8 μM,
P < 0.05) concentrations. These results are comparable with
what has been reported previously in mice (28), rats (24), and
humans (6) in response to sodium nitrate incorporation into the
diet.
The effect of sodium nitrate or nitrite supplementation on
murine mitochondrial protein expression and
phosphorylation status
The mitochondrial proteins AAC (also known as the adenine
nucleotide translocases) and UCP have been implicated in the
dissipation of mitochondrial membrane potential by facilitating
futile proton leak (34, 35). Sodium nitrate supplementation has
been reported to improve mitochondrial energetic efficiency
through decreased expression of AAC and UCP3, in particular
(6). However, when investigated we observed no alterations in
expression of these proteins in skeletal muscle in response to
supplementation with either sodium nitrate or sodium nitrite
(Figure 3).
Sodium nitrite supplementation has also been reported to
attenuate fatty acid utilization bymitochondria (27). By extension
and according to the Randle cycle (25), a reciprocal boost in
glucose utilization and PDH complex activity may be expected
to occur. Activity through the PDH complex is regulated through
phosphorylation of 3 distinct serine residues (serines 232, 293,
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FIGURE 5 Respiratory activity of skeletal muscle mitochondria isolated
from mice supplemented with sodium nitrate (n = 9 per group) for 7 d,
as assessed by Seahorse XF24 analyzer. (A) Skeletal muscle mitochondrial
respiration in response to dietary supplementation with sodium nitrate. (B)
RCRs were unchanged in response to supplementation with sodium nitrate.
(C) Mitochondrial leak was unchanged in response to sodium nitrate. No
significant differences were found between treatment and control groups (at
P < 0.05; independent t test). See the Methods section for further details.
White bars, NaCl; black bars, NaNO3. AA, antimycin A; AU, arbitrary units;
FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; OCR, oxygen
consumption rate; Oligo, oligomycin; RCR, respiratory control ratio; St2,
state 2; St3∗, state 3 (ADP at saturated concentrations).
and 300), with decreased phosphorylation of these sites corre-
sponding to increased PDH activity. The effects of sodium nitrate
or nitrite supplementation in mice on PDH phosphorylation
status in skeletal muscle are summarized in Figure 4. No
change in phosphorylation was detected with sodium nitrite
supplementation, whereas only a small change was observed
with sodium nitrate (Figure 4). These findings correlate with
no observable difference in PDH activity in response to nitrite
FIGURE 6 Respiratory activity of skeletal muscle mitochondria isolated
from mice supplemented with sodium nitrite (n = 5–6 per group) for 7 d,
as assessed by Seahorse XF24 analyzer. (A) Skeletal muscle mitochondrial
respiration in response to dietary supplementation with sodium nitrite.
Nitrite supplementation resulted in decreased oligomycin-induced respiration
when compared with control. ∗Significant differences: ∗P < 0.05. (B)
RCRs were unchanged in response to supplementation with sodium nitrite.
(C) Mitochondrial leak was unchanged in response to sodium nitrite. No
significant differences were found between treatment and control groups (at
P < 0.05; independent t test). See the Methods section for further details.
White bars, NaCl; gray bars, NaNO2. AA, antimycin A; AU, arbitrary units;
FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; OCR, oxygen
consumption rate; Oligo, oligomycin; RCR, respiratory control ratio; St2,
state 2; St3∗, state 3 (ADP at saturated concentrations).
(Supplemental Figure 1; please see Supplemental Figure 2 for
example blots).
The effect of sodium nitrate or nitrite supplementation on
murine mitochondrial energetics
After observing limited change in protein expression lev-
els, we investigated the impact of both nitrite and nitrate
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FIGURE 7 Respiratory activity of skeletal muscle mitochondria isolated
from mice supplemented with sodium nitrite (n = 8 per group) for 7 d, as
evaluated by Clark-type oxygen electrode. (A) Skeletal muscle mitochondrial
respiration in response to dietary supplementation with sodium nitrite. (B)
RCRs were unchanged in response to supplementation with sodium nitrite.
(C) Mitochondrial leak was unchanged in response to sodium nitrite. (D)
Mitochondrial P:O ratios were unchanged in response to sodium nitrite. No
significant differences were found between treatment and control groups
(at P < 0.05; independent t test). See the Methods section for further
details. White bars, NaCl; gray bars, NaNO2. AA, antimycin A; AU,
arbitrary units; CATR, carboxyatractyloside; FCCP, carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone; OCR, oxygen consumption rate; Oligo,
oligomycin; P:O, phosphate:oxygen; RCR, respiratory control ratio; St2, state
2; St3∗, state 3 (ADP at saturated concentrations).
FIGURE 8 Expression of UCP3 and AAC in human skeletal muscle after
infusion of sodium nitrite (n = 20) or placebo (n = 15). (A) Expression
of UCP3 was unchanged in human skeletal muscle in response to sodium
nitrite. (B) Expression of AAC1 was unchanged in human skeletal muscle
in response to sodium nitrite. (C) Expression of AAC2 was unchanged in
human skeletal muscle in response to sodium nitrite. (D) Expression and
phosphorylation status of PDH were unchanged in human skeletal muscle
in response to sodium nitrite. White bars, NaCl; gray bars, NaNO2. AAC,
ADP/ATP carrier protein; AU, arbitrary units; C, control; N, nitrate/nitrite;
PDH, pyruvate dehydrogenase; UCP, uncoupling protein.
supplementation on mitochondrial efficiency directly by respira-
tory analysis of isolated mitochondria. As summarized in Figure
5, sodium nitrate supplementation had no effect on mitochondrial
respiration associated with proton leak activity (OCRs in the
presence of oligomycin; Figure 5A, C), coupling efficiency
(e.g., the respiratory control ratio; Figure 5B), or respiratory
activity in any of the conditions tested. In contrast, sodium
nitrite supplementation appeared to decrease mitochondrial
activity in the presence of oligomycin (Figure 6). However,
the respiratory control ratio (Figure 6B) remained unchanged,
suggesting that the apparent decrease was due to a general
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TABLE 1 Clinical characteristics of the human study cohort1
Placebo (n = 15) Nitrite (n = 20) P
Age, y 67 ± 10 62 ± 9 0.199
Sex, male 11 (73.3) 19 (95.0) 0.070
Height, cm 167 ± 10 172 ± 10 0.130
Weight, kg 89 ± 15 88 ± 16 0.959
Body surface area, m2 2.02 ± 0.22 2.04 ± 0.23 0.714
SBP baseline, mm Hg 131 ± 17 125 ± 19 0.356
SBP postinfusion, mm Hg 123 ± 22 117 ± 21 0.467
DBP baseline, mm Hg 76 ± 9 73 ± 10 0.383
DBP postinfusion, mm Hg 70 ± 9 68 ± 12 0.592
HR baseline, bpm 61 (56, 68) 64 (57, 72) 0.227
HR postinfusion, bpm 58 (55, 63) 64 (55, 74) 0.178
Diabetes mellitus 4 (26.7) 7 (35.0) 0.599
Myocardial infarction 7 (46.7) 7 (35.0) 0.486
Hypertension 11 (73.3) 10 (50.0) 0.163
Smoking status 0.325
Never 5 (33.3) 10 (50.0)
Ex-smoker 9 (60.0) 7 (35.0)
Current 1 (6.7) 3 (15.0)
Aspirin 12 (80.0) 13 (65.0) 0.331
β-blockers 14 (93.3) 16 (80.0) 0.265
Oral nitrates 2 (13.3) 4 (20.0) 0.605
Calcium channel blockers 4 (26.7) 4 (20.0) 0.642
ACEi/ARB 8 (53.3) 12 (60.0) 0.693
Statins 15 (100.0) 19 (95.0) 0.380
1Values are n (%), mean ± SD, or median (IQR). ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor type 2 blockers; DBP,
diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure.
decrease in respiratory activity in all conditions, and was not
specific to proton leak (Figure 6C). Further detailed analysis
at higher resolution using a Clark-type oxygen electrode in
follow-up experiments confirmed that neither proton leak activity
(Figure 7A, C), the respiratory control ratio (Figure 7B), nor P:O
ratio estimates of mitochondrial efficiency (ATP generated per
oxygen consumed; Figure 7D) had changed in response to sodium
nitrite supplementation. In contrast to previous reports (6, 14),
therefore, these results suggest that sodium nitrate and nitrite do
not altermitochondrial proton leak or coupling efficiency to affect
physiology.
Effects of sodium nitrite supplementation on human
mitochondrial protein expression
Given our observations with mice, we took the opportunity to
investigate the impact of sodium nitrite infusion on expression
of mitochondrial UCPs in human skeletal muscle of patients
scheduled for CABG surgery (Figure 8). For data on the effect
of sodium nitrite infusion on cardiac expression of mitochondrial
proteins, please see Supplemental Figures 3 and 4.
The clinical characteristics of this cohort are summarized
in Table 1, whereas pharmacokinetics of plasma NO−3 and
NO−2 in response to infusion are depicted in Figure 9. Infusion
of sodium nitrite resulted in an immediate increase in plasma
NO−2 concentrations, whereas plasma NO
−
3 concentrations had
increased by 6 h postinfusion.
Infusion of sodium nitrite before surgery did not alter the
expression of UCP3, AAC1, or AAC2 in human skeletal muscle.
Similarly, PDH expression and phosphorylation status remained
unchanged. These findings in humans are consistent with our
findings in mice, where little or no change in these proteins was
observed.
Discussion
Numerous studies have reported on improved exercise per-
formance in healthy participants in response to ingestion of
inorganic nitrate (4, 5, 7, 13, 14, 36). The inclusion of
inorganic nitrate into the diet, whether through dietary sources
(e.g., beetroot, spinach) or through other therapeutic avenues
(e.g., supplements), has been consistently reported to improve
muscle performance (8, 13, 37) and to decrease the oxygen
cost of submaximal exercise (4, 5, 7, 14), with no detectable
changes in plasma substrate concentrations (7, 14, 36). These
improvements in exercise performance have also been observed
in cardiovascular diseases such as stable angina (38), and heart
failure with either preserved (9) or reduced (10) ejection fraction.
Based in part on data obtained via near infrared spectroscopy
(NIRS), as well as unchanged plasma substrate concentrations,
it was postulated that the exercise benefits of inorganic nitrate
could be attributed to improvements in mitochondrial efficiency,
specifically increased coupling of mitochondrial respiration to
ATP generation, through decreased expression of AAC and
UCP3 and reduced proton leak activity (6). Given the canonical
understanding of the entero-salivary circuit for absorption of
exogenous nitrates (39, 40), together with the observations
regarding NO and mitochondrial respiration (41), these findings
provide an attractive mechanism to account for the apparent
exercise benefits of inorganic nitrates.
It should be noted that studies using the NIRS technique have
shown reduced muscle oxygen consumption after ingestion of
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FIGURE 9 Plasma concentrations of NO−3 and NO
−
2 in humans over
time in response to a 30-min bolus injection of sodium nitrite or saline
placebo (see theMethods section for details). (A) PlasmaNO−3 concentrations
were significantly increased 6 h postinfusion in patients receiving intravenous
sodium nitrite (F[1,18] = 9.44). ∗∗Significant differences: ∗∗P < 0.01. (B)
Plasma NO−2 concentrations were significantly increased immediately postin-
fusion in patients receiving intravenous sodium nitrite (F[1,32] = 27.342).
∗∗Significant differences: ∗∗P < 0.01. White circles, NaCl; gray circles,
NaNO2.
inorganic nitrate (4), but this is directly related to alterations
in regional blood flow (42, 43). This is particularly relevant
when considering the known vasodilator properties of nitrite,
the putative active component of inorganic nitrate (1, 15, 44–
46). Using quantitative fMRI, reductions in muscle oxygen
consumption at submaximal exercise with inorganic nitrate were
shown to be more prominent in muscles with higher proportions
of type 1 fibers, suggesting a mitochondrial, rather than vascular,
effect (47). However, previous human studies have observed that
oral inorganic nitrate does not alter glucose uptake nor insulin
sensitivity (36).
Importantly, our investigation failed to find any alterations in
mitochondrial respiration in response to inorganic nitrite, nor
were any changes in expression of the proteins AAC1, AAC2,
or UCP3 observed in either human or murine skeletal muscle
tissue. Indeed, recent work by others has also cast doubt on the
idea that inorganic nitrate improves mitochondrial respiratory
efficiency: whereas there was a slight reduction in whole body
oxygen consumption, Whitfield et al. (23) observed no changes
in mitochondrial respiration or UCP content in response to
inorganic nitrate (ingested as beetroot juice) (23). Furthermore,
we found no substantive changes in the phosphorylation status
of the PDH complex, nor any increase in PDH activity. As
such, there is now a growing body of evidence to indicate that
previously observed exercise benefits in response to inorganic
nitrate/nitrite are unlikely due to improvements in mitochondrial
oxygen efficiency.
There are some limitations to the present study which need
to be acknowledged. Although broadly similar, plasma NO−3 and
NO−2 concentrations in our murine cohorts were slightly higher
than what has been reported previously (28). In addition, we
collected no functional data to complement our physiological
data. With regards to our human data, plasma NO−3 and NO
−
2
concentrations at the time of biopsy were similar to those at
baseline, although this does not preclude the possibility of long-
lasting effects: indeed, we have recently reported on a persulfide-
signaling-based mechanism whereby sodium nitrite may induce
long-lasting effects in vascular tissue (48). Lastly, this investiga-
tion does not address the possibility of divergent effects between
dietary nitrate and dietary nitrite supplementation: dietary nitrate
supplementation was observed to reduce whole body oxygen
consumption (while leaving the respiratory exchange ratio and
indexes of glucose handling unchanged), yet infusion with
sodium nitrite failed to demonstrate the same effects (36). These
results were replicated to an extent in mice and humans (23, 24),
where supplementation with nitrate-rich beetroot juice or sodium
nitrate solution also reduced whole body oxygen consumption.
These latter studies reported similar results to our own in that
they did not observe any reductions in mitochondrial leak nor
improvements in mitochondrial coupling efficiency.
The evidence underlying the vascular effects of inorganic
nitrate/nitrite remains convincing, however. Hypoxic potentiation
of inorganic nitrite as a vasodilator, and its augmentation in the
presence of hemoglobin, have been reported previously (15), and
similar work has reported a seeming dependence on myoglobin
for the vascular effects of nitrite (49). In a clinical study involving
chronic HFrEF patients, nitrite infusion resulted in decreases
in pulmonary vascular resistance and right atrial pressure, as
well as increased stroke volume, correlating with increased
estimated transseptal gradient (defined as pulmonary capillary
wedge pressure minus right atrial pressure), with alleviation of
diastolic ventricular interaction suggested as a likely mechanism
(45). Similar effects have also been observed in response to
inhaled nitrite in HFpEF patients (50, 51). Elucidation of the
mechanisms underlying the vascular effects of nitrite, however,
is beyond the scope of the present investigation.
The therapeutic benefits of inorganic nitrate/nitrite are unlikely
to be due to direct modulation of skeletal muscle mitochondrial
metabolism. These results do not preclude that the underlying
benefits of inorganic nitrite may be mediated through vascular
effects: indeed, modulation of vascular function may even
account for previous reports of altered metabolism in response
to inorganic nitrate/nitrite.
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